WIC
GSK icon

Willis Investment Counsel’s GSK GSK Stock Holding History

Willis Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-76,320
Closed -$8.11M – 112
2019
Q1 		$8.11M Sell
76,320
-361,120
-83% -$18M 0.56% 64
2018
Q4 		$20.9M Sell
437,440
-5,040
-1% -$248K 1.55% 17
2018
Q3 		$22.2M Sell
442,480
-34,320
-7% -$1.74M 1.53% 18
2018
Q2 		$24M Sell
476,800
-13,920
-3% -$701K 1.77% 8
2018
Q1 		$24M Buy
490,720
+71,600
+17% +$3.33M 1.85% 9
2017
Q4 		$18.6M Buy
419,120
+6,960
+2% +$322K 1.31% 27
2017
Q3 		$20.9M Buy
412,160
+12,800
+3% +$649K 1.51% 18
2017
Q2 		$21.5M Hold
399,360
– – 1.63% 9
2017
Q1 		$21M Buy
399,360
+8,160
+2% +$414K 1.58% 13
2016
Q4 		$18.8M Buy
391,200
+53,680
+16% +$2.65M 1.41% 25
2016
Q3 		$18.2M Buy
337,520
+10,800
+3% +$592K 1.46% 19
2016
Q2 		$17.7M Buy
326,720
+4,080
+1% +$215K 1.51% 15
2016
Q1 		$16.4M Buy
322,640
+20,000
+7% +$996K 1.44% 20
2015
Q4 		$15.3M Hold
302,640
– – 1.39% 21
2015
Q3 		$14.5M Buy
302,640
+24,960
+9% +$1.3M 1.42% 15
2015
Q2 		$14.5M Buy
277,680
+28,872
+12% +$1.63M 1.37% 18
2015
Q1 		$14.4M Buy
248,808
+33,760
+16% +$1.94M 1.33% 18
2014
Q4 		$11.5M Sell
215,048
-52,480
-20% -$2.94M 1.08% 32
2014
Q3 		$15.4M Buy
267,528
+29,040
+12% +$1.78M 1.62% 20
2014
Q2 		$15.9M Buy
238,488
+9,200
+4% +$623K 1.56% 20
2014
Q1 		$15.3M Sell
229,288
-1,680
-0.7% -$114K 1.55% 20
2013
Q4 		$15.4K Buy
230,968
+35,040
+18% +$2.27M 0.72% 21
2013
Q3 		$12.2M Hold
195,928
– – 1.4% 27
2013
Q2 		$12.2M Buy
+195,928
New +$12.4M 1.4% 27

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Willis Investment Counsel's GSK Position: Q2 2019 in Review

Willis Investment Counsel sold out of GSK (GSK) in Q2 2019, closing a stake of 76,320 shares — an estimated $8.11M sold.

Willis Investment Counsel first reported a position in GSK in Q2 2013 and held it in 24 quarters. The position peaked at $24M in Q2 2018. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

  • Willis Investment Counsel reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
  • Willis Investment Counsel sold 76,320 GSK shares in Q2 2019, an estimated $8.11M.
  • Willis Investment Counsel first reported a position in GSK in Q2 2013 and held it in 24 quarters.
  • Willis Investment Counsel's GSK position peaked at $24M in Q2 2018.
  • 804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Willis Investment Counsel's 13F filing for Q2 2019, filed 14 Aug 2019.